fig6
From: Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study
Figure 6. Swimmer’s plot of PFS across molecular alterations. PFS: Progression-free survival; ALK: anaplastic lymphoma kinase; HER2: human epidermal growth factor receptor 2; BRAF: V-raf murine sarcoma viral oncogene homolog; RET: rearranged during transfection; ROS1: c-ros oncogene 1; ECOG: Eastern Cooperative Oncology Group; ICI: immune checkpoint blockade.
